Intelgenx Technologs Stock Performance
| IGXT Stock | USD 0.17 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Intelgenx Technologs are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Intelgenx Technologs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Intelgenx Technologs is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 1.2 M | |
| Total Cashflows From Investing Activities | -5.1 M |
Intelgenx |
Intelgenx Technologs Relative Risk vs. Return Landscape
If you would invest 17.00 in Intelgenx Technologs on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Intelgenx Technologs or generate 0.0% return on investment over 90 days. Intelgenx Technologs is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Intelgenx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Intelgenx Technologs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Intelgenx Technologs' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Intelgenx Technologs, and traders can use it to determine the average amount a Intelgenx Technologs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| IGXT |
Based on monthly moving average Intelgenx Technologs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Intelgenx Technologs by adding Intelgenx Technologs to a well-diversified portfolio.
Intelgenx Technologs Fundamentals Growth
Intelgenx Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Intelgenx Technologs, and Intelgenx Technologs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Intelgenx Pink Sheet performance.
| Return On Equity | -5.29 | |||
| Return On Asset | -0.37 | |||
| Operating Margin | (7.39) % | |||
| Current Valuation | 30.97 M | |||
| Shares Outstanding | 174.65 M | |||
| Price To Earning | (55.38) X | |||
| Price To Book | 11.54 X | |||
| Price To Sales | 19.11 X | |||
| Revenue | 1.53 M | |||
| EBITDA | (7.04 M) | |||
| Cash And Equivalents | 6.98 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 6.21 M | |||
| Debt To Equity | 6.42 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (7.17 M) | |||
| Earnings Per Share | (0.07) X | |||
| Total Asset | 17.91 M | |||
| Retained Earnings | (42.6 M) | |||
| Current Asset | 4.17 M | |||
| Current Liabilities | 1.78 M | |||
About Intelgenx Technologs Performance
Assessing Intelgenx Technologs' fundamental ratios provides investors with valuable insights into Intelgenx Technologs' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Intelgenx Technologs is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada. Intelgenx Technologs operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about Intelgenx Technologs performance evaluation
Checking the ongoing alerts about Intelgenx Technologs for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Intelgenx Technologs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Intelgenx Technologs generated a negative expected return over the last 90 days | |
| Intelgenx Technologs has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 1.53 M. Net Loss for the year was (9.31 M) with loss before overhead, payroll, taxes, and interest of (721 K). | |
| Intelgenx Technologs currently holds about 6.98 M in cash with (7.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Roughly 23.0% of the company shares are held by company insiders |
- Analyzing Intelgenx Technologs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Intelgenx Technologs' stock is overvalued or undervalued compared to its peers.
- Examining Intelgenx Technologs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Intelgenx Technologs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Intelgenx Technologs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Intelgenx Technologs' pink sheet. These opinions can provide insight into Intelgenx Technologs' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Intelgenx Pink Sheet Analysis
When running Intelgenx Technologs' price analysis, check to measure Intelgenx Technologs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelgenx Technologs is operating at the current time. Most of Intelgenx Technologs' value examination focuses on studying past and present price action to predict the probability of Intelgenx Technologs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelgenx Technologs' price. Additionally, you may evaluate how the addition of Intelgenx Technologs to your portfolios can decrease your overall portfolio volatility.